Literature DB >> 23557335

Role of cancer-related inflammation in esophageal cancer.

Mingxin Zhang1, Suna Zhou, Lingmin Zhang, Wenguang Ye, Qinsheng Wen, Jingjie Wang.   

Abstract

Esophageal cancer (EC) is the ninth most common malignancy with a poor prognosis. It is clear that improvements need to be made to reveal the exact molecular mechanisms of EC. Cancer-related inflammation (CRI) recently has been proposed as a major physiological hallmark of malignancy and has important value in diagnosis, treatment, and prognosis. But the role of CRI in EC has remained unclear. In this review, we focus primarily on the function of key mediators of CRI in EC, including transcription factors, chemokines, cytokines, reactive oxygen species, COX-2, and specific microRNAs. Through a comprehensive analysis, we try to reveal the interaction between CRI and EC, providing novel preventive, diagnostic, and therapeutic strategies to reduce the health burden of EC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23557335     DOI: 10.1615/critreveukargeneexpr.2013006033

Source DB:  PubMed          Journal:  Crit Rev Eukaryot Gene Expr        ISSN: 1045-4403            Impact factor:   1.807


  8 in total

1.  [Effects of anti-infection treatment on expressions of HLA-DR and CD86 in dendritic cells in rabbit buccal VX2 squamous cell carcinoma tissue with inflammation].

Authors:  Zhang Lin; Zhang Nini; Huang Guilin; Hu Xiaohua; Yi Jie; Yao Li
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2015-04

2.  Mitogen activated protein kinase kinase kinase 3 (MAP3K3/MEKK3) overexpression is an early event in esophageal tumorigenesis and is a predictor of poor disease prognosis.

Authors:  Raghibul Hasan; Rinu Sharma; Anoop Saraya; Tushar K Chattopadhyay; Siddartha DattaGupta; Paul G Walfish; Shyam S Chauhan; Ranju Ralhan
Journal:  BMC Cancer       Date:  2014-01-02       Impact factor: 4.430

3.  miR-302b inhibits cancer-related inflammation by targeting ERBB4, IRF2 and CXCR4 in esophageal cancer.

Authors:  Mingxin Zhang; Lingmin Zhang; Manli Cui; Wenguang Ye; Pengjiang Zhang; Suna Zhou; Jingjie Wang
Journal:  Oncotarget       Date:  2017-07-25

4.  Sensitivity value of hematological markers in patients receiving chemoradiotherapy for esophageal squamous cell carcinoma.

Authors:  Shan Zhu; Chuan-Wang Miao; Zhong-Tang Wang; Li Peng; Baosheng Li
Journal:  Onco Targets Ther       Date:  2016-10-13       Impact factor: 4.147

Review 5.  Dietary Inflammatory Index and Non-Communicable Disease Risk: A Narrative Review.

Authors:  Catherine M Phillips; Ling-Wei Chen; Barbara Heude; Jonathan Y Bernard; Nicholas C Harvey; Liesbeth Duijts; Sara M Mensink-Bout; Kinga Polanska; Giulia Mancano; Matthew Suderman; Nitin Shivappa; James R Hébert
Journal:  Nutrients       Date:  2019-08-12       Impact factor: 5.717

Review 6.  Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy.

Authors:  Ajaz A Bhat; Sabah Nisar; Selma Maacha; Tatiana Correa Carneiro-Lobo; Sabah Akhtar; Kodappully Sivaraman Siveen; Nissar A Wani; Arshi Rizwan; Puneet Bagga; Mayank Singh; Ravinder Reddy; Shahab Uddin; Jean-Charles Grivel; Gyan Chand; Michael P Frenneaux; Mushtaq A Siddiqi; Davide Bedognetti; Wael El-Rifai; Muzafar A Macha; Mohammad Haris
Journal:  Mol Cancer       Date:  2021-01-04       Impact factor: 27.401

Review 7.  The Role of Tumor Microenvironment in Invasion and Metastasis of Esophageal Squamous Cell Carcinoma.

Authors:  Shuyue Zheng; Beilei Liu; Xinyuan Guan
Journal:  Front Oncol       Date:  2022-06-22       Impact factor: 5.738

8.  Combined neutrophil-platelet score and hemoglobin level predict survival in esophageal squamous cell carcinoma patients treated with chemoradiotherapy.

Authors:  Chuanwang Miao; Shan Zhu; Hong Pan; Xiaolan Cao; Shuanghu Yuan; Xudong Hu
Journal:  Oncotarget       Date:  2017-09-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.